Mimedx (MDXG) Equity Average (2011 - 2026)

Mimedx's Equity Average history runs 16 years deep, the most recent figure standing at $249.7 million for Q1 2026.

• In Q1 2026, Equity Average rose 26.17% year-over-year to $249.7 million; the TTM figure through Mar 2026 stood at $249.7 million (up 26.17% YoY), while the FY2025 annual figure was $224.8 million, up 33.9% from the prior year.
• Equity Average came in at $249.7 million for Q1 2026 at Mimedx, up from $247.7 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $249.7 million in Q1 2026 to a low of -$18.8 million in Q4 2022.
• A 5-year average of $105.2 million and a median of $149.2 million in 2024 frame the typical range for Equity Average.
• Across the five-year window, Equity Average plunged 555.05% in 2022 and soared 3179.11% in 2024, its largest moves.
• Mimedx's Equity Average stood at -$18.8 million in 2022, then jumped by 484.04% to $72.0 million in 2023, then soared by 159.72% to $187.1 million in 2024, then surged by 32.44% to $247.7 million in 2025, then climbed by 0.81% to $249.7 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $249.7 million, $247.7 million, and $227.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison